Clinical trials: Ethnic Group
Academic Performance, Anxiety
Mindful Minds: Mindfulness-Based Neurofeedback for Underrepresented College Students
The study examines the efficacy of a mindfulness-based neurofeedback protocol designed to improve academic performance and reduce performance anxiety in racial and ethnic minority college students.
- Trial name
- NCT06784934
- Testing
- NeuroSky Mindfulness-Based Neurofeedback
- Where
- United States
- Volunteers
- 39 people, healthy volunteers welcome
- Sponsor
- Florida International University
Diabetes
Enhanced DPP-GLB to Promote Weight Loss Among Nonresponders in a Community-Based Lifestyle Intervention.
This study seeks to establish the efficacy of identifying weight loss nonresponders early in a Diabetes Prevention Program (DPP) intervention in 20 community settings (primarily churches and community centers) and providing them…
- Trial name
- NCT04757519
- Testing
- DPP-GLB Standard, DPP-GLB Enhanced
- Where
- 21 sites in United States
- Volunteers
- 403 people, healthy volunteers welcome
- Sponsor
- Lovoria Williams
Schizophrenia
Biomarker and Safety Study of Clozapine in Patients With Benign Ethnic Neutropenia (BEN)
Clozapine (CLZ) is the most effective antipsychotic for treatment-refractory schizophrenia (SZ). Despite the overwhelming evidence of superior efficacy, CLZ is infrequently prescribed in the US, at a considerably lower rate than…
- Trial name
- BEN (NCT02404155)
- Testing
- Clozapine
- Where
- United States
- Volunteers
- 274 people
- Sponsor
- University of Maryland, Baltimore
Depression, Anxiety
Building Community Capacity for Disability Prevention for Minority Elders (Positive Minds - Strong Bodies)
The primary intervention offered through this study is a manualized and culturally adapted CBT intervention combined with an exercise intervention, administered by trained Community Health Workers and exercise trainers to ethnic…
- Conditions
- Depression, Anxiety, Physical Disability
- Trial name
- NCT02317432
- Testing
- Comparison of a combined CBT + exercise intervention and enhanced usual care
- Where
- 8 sites in United States, Puerto Rico
- Volunteers
- 307 people, healthy volunteers welcome
- Sponsor
- Massachusetts General Hospital
Acne Scars
Comparison of 1,550-nm Laser and Fractional Radiofrequency Microneedle for the Treatment of Acne Scars in Ethnic Skin
The primary objective of this randomized, split-face, controlled study is to compare the efficacy and safety of a erbium-doped 1,550-nm non-ablative fractional laser and a bipolar fractional radiofrequency microneedle device for…
- Trial name
- NCT03380845
- Testing
- Fraxel Restore, Fractora
- Where
- United States
- Volunteers
- 4 people, healthy volunteers welcome
- Sponsor
- Massachusetts General Hospital
Type 2 Diabetes Mellitus
Effect of SCH 497079 on Metabolic Parameters and Influence of Race/Ethnic Origin on Therapeutic Response (Study P05338)(COMPLETED)
The purpose of this study is to evaluate the effect of SCH 497079 on metabolic parameters and to determine the influence of race/ethnic origin on therapeutic response.
- Trial name
- NCT00673465
- Testing
- SCH 497079, Metformin
- Volunteers
- 17 people
- Sponsor
- Merck Sharp & Dohme LLC
Prostate Cancer
PACCT: Partnering Around Cancer Clinical Trials
This research has the overall goal of increasing rates at which African American and White men with prostate cancer make an informed decision to participate in a cancer clinical trial.
- Trial name
- NCT02906241
- Testing
- Patients: Questions to Ask Your Doctor: A Workbook for Patient-Doctor Teams, Physicians: Educational Module
- Where
- 2 sites in United States
- Volunteers
- 316 people
- Sponsor
- Susan Eggly
Lung Neoplasms
An Observational Study of the Ethnic Impact of Patients Undergoing Second (2nd) Line Treatment for Non-Small Cell Lung Cancer Using Pemetrexed
This large, non-randomized observational study is being conducted to provide data about the impact of ethnic origin on outcomes and resource utilization during the 2nd line treatment of non-small cell lung cancer (NSCLC) in a…
- Trial name
- NCT00497770
- Testing
- Pemetrexed
- Where
- 38 sites in United States, Puerto Rico
- Volunteers
- 434 people
- Sponsor
- Eli Lilly and Company
HIV/AIDS, Cardiovascular Diseases
Pathways to Cardiovascular Disease Prevention (DCRI Central and Statistical Coordinating Center)
The goal of this research is to generate evidence-based recommendations for the management of cardiovascular disease (CVD) risk in People Living with HIV (PLWH).
- Trial name
- NCT04025125
- Where
- United States
- Volunteers
- 2,039 people
- Sponsor
- Duke University
Chronic Kidney Disease
Multicultural Healthy Diet in Chronic Kidney Disease
This is a pilot intervention study to evaluate the feasibility and acceptability of a culturally-tailored anti-inflammatory diet intervention in participants with chronic kidney disease.
- Trial name
- NCT05504850
- Testing
- Multicultural Health Diet
- Where
- United States
- Volunteers
- 18 people
- Sponsor
- Montefiore Medical Center
Mental Health Wellness 1, Sexual Orientation
Sexual and Gender Minority Emerging Adults Eliciting Narratives
Critical narrative interventions (CNIs) have not been examined for addressing psychological outcomes (e.g., depression, anxiety, self-esteem, empowerment, psychological well-being) within sexual and gender minority emerging…
- Conditions
- Mental Health Wellness 1, Sexual Orientation, Gender Identity
- Trial name
- SEEN (NCT05899218)
- Testing
- Critical Narrative Development
- Where
- United States
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- University of Pennsylvania
Diabetes
Racial/Ethnic Differences in Trust/Mistrust and Its Effect on Diabetes Outcomes
1. Determine racial/ethnic differences in trust in physicians and mistrust of the health care system among veterans with Type 2 Diabetes. 2.
- Trial name
- NCT00383110
- Where
- United States
- Volunteers
- 300 people
- Sponsor
- US Department of Veterans Affairs
Asthma
Study of Asthma Phenotypes and Pharmacogenomic Interactions by Race-Ethnicity (SAPPHIRE)
Inhaled corticosteroids (ICS) are considered first-line treatment for persistent asthma, yet little is known about the genetic factors that influence response to this therapy.
- Trial name
- SAPPHIRE (NCT01142947)
- Testing
- beclomethasone dipropionate
- Where
- United States
- Volunteers
- 362 people
- Sponsor
- Henry Ford Health System